Emcure Pharmaceuticals Shares Locked In Upper Circuit Post Q4 Profit Jump, Margin Growth
Emcure Pharmaceuticals Ltd.'s share price soared to hit upper circuit on Friday after its net profit jumped in the fourth quarter of fiscal 2025.
The pharma company reported a 64% surge in net profit to Rs 189 crore in the quarter ended March 31, 2025. This compares to Rs 115.16 crore profit reported in the same quarter last year.
Revenue also increased to Rs 2,116 crore from Rs 1,771 crore in the year ago period.
Margins expanded to 19% from 17.53%. Additionally the company announced a dividend of Rs 3 per share.
Emcure has also recommended a final dividend of Rs 3 per share, subject to approval of the Members of the company at the ensuing Annual General Meeting.
Moreover, the company informed the exchanges on Thursday that its board of directors has approved the incorporation of a wholly-owned subsidiary, called Emcure Generics Pvt. in Pune, Maharashtra, India through a filing.
Emcure Share Price Today
The share price rose as much as 9.99% to Rs 1,284 apiece, the highest level since Feb. 7, 2025. The stock was locked in upper circuit as of 12:30 p.m. This compares to a 1.02% advance in the NSE Nifty 50.
It has fallen 11.24% on a year-to-date basis. Total traded volume so far in the day stood at 4.6 times its 30-day average. The relative strength index was at 69.21.
Out of three analysts tracking the company, two maintain a 'buy' rating and one recommends 'hold', according to Bloomberg data. The average 12-month consensus price target implies an upside of 13.5%.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
